COVID-19 reinfections in The Gambia by phylogenetically distinct SARS-CoV-2 variants-first two confirmed events in west Africa.
At the beginning of the COVID-19 pandemic, in early 2020, the scientific community hypothesised that SARS-CoV-2 transmission would eventually be hindered by herd immunity, conferred by natural infection, vaccination, or both.1 However, essential questions about whether infection with SARS-CoV-2 confers protection against reinfection and the length of time the protection lasts after either infection or vaccination remain open. These answers are crucial for the development of appropriate health control measures worldwide and become more important as new viral variants spread.
Item Type | Article |
---|---|
Elements ID | 161525 |
Explore Further
Read more research from the creator(s):
- Sanyang, Bakary
- Kanteh, Abdoulie
- Usuf, Effua
- Wariri, Oghenebrume
- Cerami, Carla
- Forrest, Karen
- D'Alessandro, Umberto
- Roca, Anna
Find work associated with the faculties and division(s):
- Dept of Disease Control
- Dept of Infectious Disease Epidemiology
- GM-Disease Control and Elimination Theme
- GM-Nutrition Theme
- GM-General Administration
- GM-Gambia Clinical Services/Comms
Find work associated with the research centre(s):
Find work from this publication: